Close
Close
CJC-1295 / Ipamorelin Nasal Spray

CJC-1295 / Ipamorelin Nasal Spray 3-Month Membership Program

$1,075.00

4.9 Avg. Rating

1000+ Reviews

  • Follow-up Exam
  • Lab Review
  • Dose Adjustments
  • Certificate of Authenticity
  • 503A Pharmacies
  • 99% Pure
  • US-based Peptides
CJC-1295 and Ipamorelin are two peptides that are often used together because they support the body’s natural growth hormone release through two different, complementary pathways. CJC-1295 is a longer-acting version of GHRH, the same natural hormone signal discussed in growth hormone research for decades. Ipamorelin works through a different natural pathway, one connected to the hormone ghrelin, which is best known for its role in hunger but also plays a part in growth hormone release.
Because these two peptides work on different signals, some providers combine them with the goal of supporting a more complete and natural growth hormone release pattern than either peptide might provide alone. This combination has become one of the more commonly discussed peptide pairings in wellness and longevity medicine.
Patients often ask about CJC-1295 / Ipamorelin because they are interested in supporting healthy aging, recovery, sleep, and body composition without introducing growth hormone directly into the body. Like Sermorelin, this combination is designed to work with your body’s own production system rather than replace it.
This combination is available in different delivery forms, including injectable and nasal spray options. The nasal spray formulation is often considered by patients who would prefer not to use injections, though it is important to understand how the nasal route may affect absorption, which is explained further below.
This page is intended to give you a clear, honest overview of CJC-1295 / Ipamorelin so you can have an informed discussion with a licensed medical provider.
Imagine your pituitary gland as a factory with two separate doorbells. One doorbell is rung by GHRH, telling the factory it is time to start releasing growth hormone. The second doorbell is rung by a different signal, connected to ghrelin, which also encourages the release of growth hormone but through its own separate pathway. CJC-1295 is designed to ring the first doorbell for a longer period of time than the body’s own natural GHRH typically would, which is why it is often described as “longer-acting.” Ipamorelin is designed to ring the second doorbell, mimicking the ghrelin-related signal in a very selective way, without strongly affecting other hormones like cortisol. When both doorbells are rung together, some research suggests the combined signal may encourage a more robust natural growth hormone release than using either peptide on its own. The pituitary gland is still the one doing the actual work of producing and releasing growth hormone; these peptides simply help send stronger and more complete signals. With the nasal spray formulation, both peptides are absorbed through the nasal tissue rather than delivered by injection under the skin. Because these are still relatively large peptide molecules, researchers continue to study how consistently and completely they are absorbed through the nasal lining compared to injectable delivery.
  • May help support the body’s natural growth hormone release through two complementary signaling pathways
  • May help promote improved sleep quality, since deep sleep is closely tied to natural growth hormone release
  • May assist with maintaining lean muscle mass as part of a broader fitness and wellness routine
  • May help support recovery time following exercise or physical activity
  • May help promote healthy body composition when paired with proper nutrition and exercise habits
  • Is currently being studied for its potential role in supporting metabolic health and vitality in aging adults
Patients commonly ask their provider about CJC-1295 / Ipamorelin for reasons such as:
  • Healthy aging support as natural growth hormone signaling declines with age
  • Athletic recovery and performance support
  • Weight management as part of a broader, medically supervised plan
  • Muscle maintenance, especially for adults focused on long-term strength and mobility
  • Joint support as part of an overall recovery and wellness strategy
  • General wellness optimization and longevity-focused care
This combination is not intended for everyone, and it should only be considered after a licensed provider has evaluated your individual health history and goals.
CJC-1295 and Ipamorelin have each been studied individually, primarily through injectable delivery, for their effects on growth hormone release, sleep, and body composition. Research on GHRH analogs like CJC-1295 and selective ghrelin-pathway peptides like Ipamorelin has generally shown that they can meaningfully increase growth hormone release in the body, with a relatively favorable safety profile in supervised settings. Research specifically on combining the two peptides is more limited than research on each peptide separately, and research on nasal spray delivery for this combination is even more limited than research on injectable forms. As with other peptides, the tissue lining the nose presents challenges for consistent absorption of larger peptide molecules, and scientists are still working to understand how nasal delivery compares to injection for this particular combination. Because the evidence base for nasal delivery is still developing, patients should understand that outcomes may vary more than they would with more thoroughly studied injectable forms. Ongoing research continues to explore both the individual and combined effects of these peptides, as well as how delivery method influences results.
CJC-1295 / Ipamorelin is generally well tolerated when used under medical supervision, but side effects are possible. These can include mild nasal irritation with spray use, headache, flushing, temporary water retention, dizziness, or changes in appetite, since Ipamorelin works through a pathway related to hunger signaling. This combination may not be appropriate for individuals with certain pituitary conditions, active cancer, uncontrolled diabetes, or other specific health histories. A complete medical evaluation is necessary before starting therapy to help identify whether this option is reasonable for you. Ongoing medical supervision is an important part of using this peptide combination safely. A licensed provider can monitor your progress, review relevant lab work, and make adjustments to your treatment plan as needed. Following your prescribed treatment plan closely helps support both your safety and the overall experience of therapy.

What does CJC-1295 / Ipamorelin nasal spray do?

It is designed to support your body’s natural growth hormone release through two different signaling pathways working together.

How long before I may notice changes?

Some patients notice changes in sleep or energy within a few weeks, while other changes, such as body composition, may take longer. Responses vary from person to person.

Is it an injection?

No. This version is a nasal spray. Injectable forms of CJC-1295 / Ipamorelin are also available.

Is the nasal spray as effective as the injectable version?

Research on nasal absorption for this peptide combination is more limited than research on injectable delivery. Your provider can help set realistic expectations based on current evidence.

Can it be combined with other peptides?

Some patients use this combination alongside other peptides, such as Sermorelin, as part of a broader plan designed by their provider.

Can it be combined with GLP-1 medications?

This depends on your individual health profile and goals. Your provider will discuss this with you during your consultation.

Will I need lab work?

Lab work is often recommended before starting and may be reviewed periodically throughout treatment to help guide your plan.

Who should avoid this peptide combination?

Individuals with certain pituitary disorders, active cancer, or other specific health conditions may not be good candidates. This is determined during your medical evaluation.

How long do patients typically remain on therapy?

Length of treatment varies based on individual goals and response, often structured around a three-month evaluation period.

Is a consultation required?

Yes. A telehealth consultation with a licensed provider is required before starting therapy.
Every peptide treatment program at SevenHealth is designed to be thorough, transparent, and medically supervised. When you begin CJC-1295 / Ipamorelin therapy with us, your treatment includes:
  • An initial telehealth medical history and comprehensive evaluation with a licensed medical provider
  • Review of previous laboratory results when available, or recommendations for laboratory testing when medically appropriate
  • Personalized treatment recommendations based on your individual medical history and goals
  • Three months of prescribed peptide therapy when medically appropriate
  • A customized dosing and titration schedule specific to your prescribed peptide
  • A comprehensive follow-up appointment approximately three months after starting treatment
  • Review of progress, discussion of results, treatment adjustments if medically appropriate, and continued provider guidance
  • Ongoing provider oversight throughout your treatment program
  • No additional fees for appointments included within the treatment program
  • No additional fees for laboratory review as part of your treatment
Our goal at SevenHealth is to make peptide therapy simple, transparent, and medically supervised from your very first consultation through your follow-up appointment and beyond. We want you to feel informed and supported at every step of your treatment journey.
SevenHealth focuses on individualized, medically supervised care rather than a one-size-fits-all approach. Patients choose SevenHealth because we offer:
  • Personalized treatment plans built around your specific health history and goals
  • Licensed medical providers who oversee your care from start to finish
  • Provider-guided dosing rather than generic, self-directed protocols
  • Prescriptions filled through FDA-registered 503A U.S. compounding pharmacies that follow applicable quality standards
  • Ongoing medical supervision throughout your treatment program
  • A structured three-month follow-up to review your progress
  • Transparent pricing, with no surprise appointment or lab review fees within your treatment program
Our approach is designed to be educational and supportive, helping you understand your options so you and your provider can make informed decisions together.
  • CJC-1295 and Ipamorelin work through two different natural pathways to support the body’s own growth hormone release
  • CJC-1295 mimics a longer-acting GHRH signal, while Ipamorelin mimics a selective, ghrelin-related signal
  • The two peptides are often combined because they may complement each other’s effects
  • Nasal spray delivery is an alternative to injection, but current research on nasal absorption for this combination is more limited than research on injectable forms
  • Potential benefits may include support for sleep, recovery, lean muscle maintenance, and healthy aging
  • This combination is not appropriate for everyone, including certain individuals with pituitary conditions or active cancer
  • A medical evaluation and lab work help determine whether this therapy may be a reasonable option for you
  • Ongoing provider supervision is an important part of using this peptide combination safely

Educational Disclaimer

This information is provided for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Peptide therapy should only be used under the supervision of a licensed healthcare provider after an appropriate medical evaluation. Individual results may vary.

$100 OFF GLP-1 Injectable Plans for New Members ! CODE: